Renumathy Dhanasekaran

VA Palo Alto Health Care System — United States

Medicine · Health Sciences

60h-index43.4kcitations223works14.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(60), Liver Disease Diagnosis and Treatment(51), Liver Disease and Transplantation(35), Cancer Genomics and Diagnostics(30), Cholangiocarcinoma and Gallbladder Cancer Studies(20)

Publications189 total

Modeling patient tissues at molecular resolution with Eva
2025Open Access
Author Correction: Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Nature·2025Open Access
Supplementary Figures from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
2025Open Access
Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
2025Open Access
Hepatocellular Carcinoma: A Practical Anatomy-Based Guide for Staging and Treatment Planning, From the <i>AJR</i> Special Series on Critical Anatomy
American Journal of Roentgenology·2025· 2 cited
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
UNC Libraries·2025Open Access
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
UNC Libraries·2025Open Access
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
UNC Libraries·2025Open Access
The Immune Microenvironment of Transplant Glomerulitis
Kidney International Reports·2025· 1 citedOpen Access
Redefining cancer care: the case for an onco-gastroenterology subspecialty
Nature Reviews Gastroenterology & Hepatology·2025
Practical approach to diagnose and manage benign liver masses
Hepatology Communications·2024· 9 citedOpen Access
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease
Nature Cancer·2024· 35 citedOpen Access
Su1594 EVOLVING PUBLIC INTEREST IN FATTY LIVER DISEASE NOMENCLATURE: ANALYZING GOOGLE SEARCH TRENDS
Gastroenterology·2024
Su1965 DEVELOPING A HIGH-PERFORMING CUSTOMIZED AI TUMOR BOARD TOOL FOR HCC STAGING AND MANAGEMENT
Gastroenterology·2024
Sa1648 CHECKING IS LACKING: SUBOPTIMAL SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE AFTER DIRECT-ACTING ANTIVIRAL THERAPY FOR HEPATITIS C
Gastroenterology·2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma
Nature Communications·2024· 13 citedOpen Access
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Nature·2024· 192 citedOpen Access
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
Journal of Hepatology·2023· 84 citedOpen Access
Spatial Transcriptomics in HCC
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Spatial Transcriptomics in HCC
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
page 1 of 10Next →

Frequent Co-authors

Dean W. Felsher(12), Nia Adeniji(8), Costica Aloman(7), Lewis R. Roberts(6), Anja Deutzmann(5), Ponni Perumalswami(5), Hyun S. Kim(5), Jangho Park(5), Aida S. Hansen(4), Andreea M. Catana(4), Rotonya M. Carr(4), Neil Mehta(4), Ian Lai(4), Anand Rajan(4), Thomas Marjot(3), Andrew M. Moon(3), Matthew J. Armstrong(3), Tamsin Cargill(3), Aileen Marshall(3), Nneka N. Ufere(3)